Capital Access Window - Ondine Biomedical Inc.
In brief · summary, not quotable
Ondine Biomedical Inc. has requested a temporary suspension of trading for its common shares on AIM, effective from 7:30 am on September 30, 2026, pending an announcement. This suspension is part of a Capital Access Window, indicating the company is likely preparing to disclose significant financial or strategic news that could impact its share price.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your OBI notes
30/09/2026 7:30am
AIM CAPITAL ACCESS WINDOW
ONDINE BIOMEDICAL INC.
COMMON SHARES OF NO PAR VALUE, FULLY PAID (CDI)
(BNZGQK5) (CA68234M2058)
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.